Table 2.
Percent of patients with early mortality
| Early mortality, n/N (%) | P* | |
|---|---|---|
| All HDTX patients | 1187/3939 (30.1) | — |
| Year of first transplant | .002 | |
| <1997 | 238/654 (36.4) | |
| 1998-2003 | 299/997 (30.0) | |
| 2004-2008 | 362/1276 (28.4) | |
| 2009-2013 | 223/811 (27.5) | |
| ≥2014 | 65/201 (32.3) | |
| Age, y | <.0001 | |
| <65 | 798/2892 (27.6) | |
| ≥65 | 389/1047 (37.2) | |
| Sex | .92 | |
| Female | 460/1522 (30.2) | |
| Male | 727/2417 (30.1) | |
| Race/ethnicity | .30 | |
| White | 1012/3407 (29.7) | |
| African American | 130/389 (33.4) | |
| Other | 45/143 (31.5) | |
| GEP70 | <.0001 | |
| Low risk | 283/1620 (17.5) | |
| High risk | 216/352 (61.4) | |
| Any chromosomal abnormality† | <.0001 | |
| No | 550/2418 (22.8) | |
| Yes | 616/1478 (41.7) | |
| TC6 classification† | <.0001 | |
| CCND1 | 83/390 (21.3) | |
| CCND3 | 6/39 (15.4) | |
| D1 | 106/565 (18.8) | |
| D2 | 129/513 (25.2) | |
| MAF/MAFB | 63/134 (47.0) | |
| MMSET | 94/244 (38.5) | |
| On a TT protocol | <.0001 | |
| No | 810/2138 (37.9) | |
| Yes | 377/1801 (20.9) |
Early mortality defined as death within 3 years of first ASCT, patients who were censored before 3 years of follow-up were excluded from the denominator because their true length of survival is unknown resulting from loss to follow-up.
*
χ2 P value.
†
Excludes patients with missing data.